Form 4: AvePoint CEO Sells Shares for SGX Listing Liquidity

AvePoint CEO Tianyi Jiang sold 2,068,966 shares at $15.21 each to facilitate initial liquidity for the company's secondary listing on the Singapore Exchange.

Summary

• AvePoint, Inc. (AVPT) CEO and Director, Tianyi Jiang, reported a sale of 2,068,966 shares of common stock.
• The transaction occurred on September 18, 2025, at a price of $15.21 per share.
• The sale was executed to facilitate initial liquidity in connection with the company's secondary listing on the Singapore Exchange Securities Trading Limited (SGX-ST).
• The transaction was undertaken pursuant to a Rule 10b5-1(c) plan and in accordance with Rule 144 and applicable insider trading policies.
• No shares were sold on NASDAQ in connection with this specific transaction.
• Following the sale, Tianyi Jiang beneficially owns 13,841,853 shares, held indirectly through various trusts and LLCs, and by his spouse.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While an insider sale is typically viewed negatively, the explicit and strategic reason for the sale (SGX listing liquidity) and its pre-planned nature under a 10b5-1 plan mitigate concerns. The secondary listing itself is a positive strategic development.

Positives

• The sale was explicitly for a strategic corporate purpose: to facilitate initial liquidity for AvePoint's secondary listing on the Singapore Exchange (SGX-ST), which could broaden the company's investor base and market access.
• The transaction was pre-planned under a Rule 10b5-1(c) plan, indicating a structured and compliant approach to insider trading.

Negatives

• A significant insider sale of over 2 million shares, even with a stated purpose, can sometimes be perceived negatively by investors, potentially raising questions about management's confidence, despite the explanation provided.

Risks

• No specific risks beyond the general implications of insider selling are mentioned in the filing.

Future Outlook

The secondary listing on the Singapore Exchange Securities Trading Limited (SGX-ST) suggests a strategic move to expand market presence and enhance liquidity for AvePoint's shares, potentially attracting a broader international investor base.

Management Comments

• The reported sale of shares was made pursuant to the Company's secondary listing on the Singapore Exchange Securities Trading Limited ('SGX-ST') on September 18, 2025.
• The sale was executed to facilitate initial liquidity in connection with the SGX-ST listing.
• The reporting person undertook the transaction in accordance with Rule 144 and applicable insider trading policies.

Industry Context

Companies often pursue secondary listings on international exchanges like the SGX-ST to tap into new investor pools, increase trading liquidity, and enhance global visibility. This move by AvePoint aligns with a broader trend of technology companies seeking diversified market access.

Corporate Governance

Related Party Transactions

• The beneficial ownership includes shares held by Dr. Jiang's affiliate River Valley Ltd., Red Kite LLC, Capella 2022 GRAT II, Capella 2023 GRAT, Capella 2024 GRAT, Capella 2024 GRAT II (for which Dr. Jiang is trustee), and shares held by Dr. Jiang's spouse. Dr. Jiang disclaims beneficial ownership except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders: The secondary listing on SGX-ST could potentially increase liquidity and broaden the investor base, which may benefit existing shareholders.
• Investors: The transparency of the pre-planned sale for a strategic purpose provides clarity, though the large volume might still warrant scrutiny.

Next Steps

• The company's secondary listing on the Singapore Exchange Securities Trading Limited (SGX-ST) is a key upcoming or recently completed event, with the reported sale directly supporting its initial liquidity.

Key Dates

Recommendation

The sale by AvePoint's CEO, while substantial, is explicitly stated to be for a strategic corporate purpose related to the company's secondary listing on the Singapore Exchange. This context suggests it is not a signal of a negative outlook on the company's future performance but rather a planned action to facilitate market liquidity. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as it does not provide a strong impetus for either buying or selling the stock.

Keywords

AvePoint, AVPT, Tianyi Jiang, CEO, Director, Form 4, Insider Sale, Share Sale, SGX-ST, Singapore Exchange, Secondary Listing, Liquidity, Rule 10b5-1, Common Stock